The resulting activation of HIF-1 in these cancers leads to the transcriptional induction, not only of VEGF and VEGFRs, but also endothelin-1, angiopoietins, and angiopoietin receptors (Tie-1 and -2). This evidence concerns the gene HIF1A and cancer.